Close Menu

NEW YORK (GenomeWeb) – Metastatic prostate cancer may benefit from a precision medicine approach, according to a new study from Fred Hutchinson Cancer Research Center researchers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.